Decision: Favourable
Study Title:
TTRIO045/LidERA : A phase III, randomized, open-label, multicenter study evaluating the efficacy and safety of adjuvant giredestrant compared with physician’s choice of adjuvant endocrine monotherapy in patients with estrogen receptor-positive, HER2-negative, early breast cancer.
NREC Code:
21-NREC-CT-023
Decision:
Favourable
Meeting Date:
21/06/2021
Study Type:
CT application
Principal Investigator:
Prof Janice Walshe
PI Institution:
St Vincent's University Hospital
Sponsor:
F. Hoffman La Roche Ltd